Northwestern Mutual Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$70.3K Buy
3,757
+2,589
+222% +$52.4K ﹤0.01% 2446
2026
Q2
$23.4K Buy
1,168
+45
+4% +$795 ﹤0.01% 2810
2026
Q1
$18.3K Buy
1,123
+68
+6% +$1.14K ﹤0.01% 2838
2025
Q4
$17.7K Buy
1,055
+1,020
+2,914% +$17.1K ﹤0.01% 2790
2025
Q3
$543 Buy
+35
New +$479 ﹤0.01% 3627
2025
Q2
– Sell
-37
Closed -$470 – 3816
2025
Q1
$470 Buy
+37
New +$501 ﹤0.01% 3378
2024
Q1
– Sell
-3,792
Closed -$51K – 3665
2023
Q4
$51K Buy
+3,792
New +$46.7K ﹤0.01% 2046
2023
Q2
– Sell
-38
Closed -$529 – 3456
2023
Q1
$529 Buy
+38
New +$543 ﹤0.01% 3100
2022
Q3
– Sell
-445
Closed -$6K – 3235
2022
Q2
$6K Buy
+445
New +$6.72K ﹤0.01% 2669
2022
Q1
– Sell
-1,000
Closed -$19K – 3236
2021
Q4
$19K Buy
+1,000
New +$20.1K ﹤0.01% 2349
2021
Q2
– Sell
-9
Closed – – 3082
2021
Q1
$0 Buy
+9
New – ﹤0.01% 2866
2017
Q3
– Sell
-4
Closed – – 2199
2017
Q2
$0 Buy
+4
New – ﹤0.01% 2085
2016
Q4
– Sell
-45
Closed -$1K – 2430
2016
Q3
$1K Sell
45
-1,015
-96% -$19.1K ﹤0.01% 2042
2016
Q2
$18K Buy
1,060
+46
+5% +$849 ﹤0.01% 1197
2016
Q1
$18K Buy
1,014
+1,010
+25,250% +$18.3K ﹤0.01% 1228
2015
Q4
$0 Buy
+4
New – ﹤0.01% 1705

Other funds holding HQL

Northwestern Mutual Wealth Management's HQL Position: Q3 2026 in Review

Northwestern Mutual Wealth Management increased its abrdn Life Sciences Investors (HQL) stake by 222% in Q3 2026, buying an estimated $52.4K and bringing the position to 3,757 shares worth $70.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

Northwestern Mutual Wealth Management first reported a position in HQL in Q4 2015 and has held it in 16 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

  • Northwestern Mutual Wealth Management held 3,757 shares of abrdn Life Sciences Investors worth $70.3K as of Q3 2026.
  • Northwestern Mutual Wealth Management bought 2,589 abrdn Life Sciences Investors shares in Q3 2026, an estimated $52.4K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q3 2026, its #2446 holding.
  • Northwestern Mutual Wealth Management first reported a position in abrdn Life Sciences Investors in Q4 2015 and has held it in 16 quarters since.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.